☰

Hui Chen - Publications

Affiliations: 
2008-2010 Mechanical Engineering Columbia University, New York, NY 
Tree Info Similar researchers PubMed Report error

19 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Liu B, Gao S, Guo J, Kou F, Liu S, Zhang X, Feng A, Wang X, Cao G, Chen H, Liu P, Xu H, Gao Q, Yang R, Xu L, et al. Efficacy and Safety of HepaSphere Drug-Eluting Bead Transarterial Chemoembolization Combined with Hepatic Arterial Infusion Chemotherapy as the Second-Line Treatment in Advanced Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma. 11: 477-488. PMID 38463543 DOI: 10.2147/JHC.S452120  0.38
2024 Liu B, Gao S, Guo J, Kou F, Liu S, Zhang X, Feng A, Wang X, Cao G, Xu L, Chen H, Liu P, Xu H, Gao Q, Yang R, et al. High-dose oxaliplatin induces severe hypersensitivity reactions and high recurrence rates during rechallenge in patients treated with hepatic arterial infusion chemotherapy. International Immunopharmacology. 130: 111767. PMID 38430809 DOI: 10.1016/j.intimp.2024.111767  0.319
2023 Liu B, Gao S, Guo J, Kou F, Liu S, Zhang X, Wang X, Cao G, Chen H, Liu P, Xu H, Gao Q, Yang R, Zhu X. A Novel Nomogram for Predicting the Overall Survival in Patients with Unresectable HCC after TACE plus Hepatic Arterial Infusion Chemotherapy. Translational Oncology. 34: 101705. PMID 37257332 DOI: 10.1016/j.tranon.2023.101705  0.379
2022 Feng AW, Guo JH, Gao S, Kou FX, Liu SX, Liu P, Chen H, Wang XD, Xu HF, Cao G, Zhu X. A randomized phase II trial of hepatic arterial infusion of oxaliplatin plus raltitrexed versus oxaliplatin plus 5-fluorouracil for unresectable colorectal cancer liver metastases. Frontiers in Oncology. 12: 913017. PMID 36212504 DOI: 10.3389/fonc.2022.913017  0.347
2022 Cao G, Wang X, Chen H, Gao S, Guo J, Liu P, Xu H, Xu L, Zhu X, Yang R. Hepatic arterial infusion chemotherapy plus regorafenib in advanced colorectal cancer: a real-world retrospective study. Bmc Gastroenterology. 22: 328. PMID 35788189 DOI: 10.1186/s12876-022-02344-4  0.357
2022 Zheng K, Zhu X, Fu S, Cao G, Li WQ, Xu L, Chen H, Wu D, Yang R, Wang K, Liu W, Wang H, Bao Q, Liu M, Hao C, et al. Sorafenib Plus Hepatic Arterial Infusion Chemotherapy versus Sorafenib for Hepatocellular Carcinoma with Major Portal Vein Tumor Thrombosis: A Randomized Trial. Radiology. 211545. PMID 35103539 DOI: 10.1148/radiol.211545  0.384
2021 Liu BJ, Gao S, Zhu X, Guo JH, Kou FX, Liu SX, Zhang X, Wang XD, Cao G, Chen H, Liu P, Xu HF, Gao QZ, Yang RJ. Real-world study of hepatic artery infusion chemotherapy combined with anti-PD-1 immunotherapy and tyrosine kinase inhibitors for advanced hepatocellular carcinoma. Immunotherapy. PMID 34607482 DOI: 10.2217/imt-2021-0192  0.35
2021 Chen H, Nan G, Wei D, Zhai RY, Huang M, Yang WW, Xing BC, Zhu X, Xu HF, Wang XD, Zhang XY, Zhu BR, Liu P, Cao G, Gao S, et al. Hepatic artery injection of I-metuximab combined with transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: a prospective non-randomized, multicenter clinical trial. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 34475235 DOI: 10.2967/jnumed.121.262136  0.377
2021 Liu BJ, Gao S, Zhu X, Guo JH, Kou FX, Liu SX, Zhang X, Wang XD, Cao G, Chen H, Liu P, Zhu LZ, Xu HF, Yang RJ. Combination Therapy of Chemoembolization and Hepatic Arterial Infusion Chemotherapy in Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis Compared with Chemoembolization Alone: A Propensity Score-Matched Analysis. Biomed Research International. 2021: 6670367. PMID 34337041 DOI: 10.1155/2021/6670367  0.39
2020 Guo JH, Liu SX, Gao S, Kou FX, Zhang X, Wu D, Li XT, Chen H, Wang XD, Liu P, Zhang PJ, Xu HF, Cao G, Zhu LZ, Yang RJ, et al. Transarterial chemoembolization with hepatic arterial infusion chemotherapy plus S-1 for hepatocellular carcinoma. World Journal of Gastroenterology. 26: 3975-3988. PMID 32774071 DOI: 10.3748/wjg.v26.i27.3975  0.367
2020 Liu BJ, Gao S, Zhu X, Guo JH, Zhang X, Chen H, Wang XD, Yang RJ. Sorafenib combined with embolization plus hepatic arterial infusion chemotherapy for inoperable hepatocellular carcinoma. World Journal of Gastrointestinal Oncology. 12: 663-676. PMID 32699581 DOI: 10.4251/wjgo.v12.i6.663  0.376
2019 Liu B, Zhu X, Gao S, Guo J, Wang X, Cao G, Zhu L, Liu P, Xu H, Chen H, Zhang X, Liu S, Kou F. Safety and efficacy of hepatic arterial infusion chemotherapy with raltitrexed and oxaliplatin post-transarterial chemoembolization for unresectable hepatocellular carcinoma. Journal of Interventional Medicine. 2: 91-96. PMID 34805879 DOI: 10.1016/j.jimed.2019.07.006  0.375
2018 Zhang HY, Guo JH, Gao S, Chen H, Wang XD, Zhang PJ, Liu P, Cao G, Xu HF, Zhu LZ, Yang RJ, Li J, Zhu X. Effect of primary tumor side on survival outcomes in metastatic colorectal cancer patients after hepatic arterial infusion chemotherapy. World Journal of Gastrointestinal Oncology. 10: 431-438. PMID 30487954 DOI: 10.4251/wjgo.v10.i11.431  0.344
2017 Zhang H, Guo J, Gao S, Zhang P, Chen H, Wang X, Li X, Zhu X. Prognostic factors for transarterial chemoembolization combined with sustained oxaliplatin-based hepatic arterial infusion chemotherapy of colorectal cancer liver metastasis. Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu. 29: 36-44. PMID 28373752 DOI: 10.21147/j.issn.1000-9604.2017.01.05  0.368
2017 Guo JH, Zhang HY, Gao S, Zhang PJ, Li XT, Chen H, Wang XD, Zhu X. Hepatic artery infusion with raltitrexed or 5-fluorouracil for colorectal cancer liver metastasis. World Journal of Gastroenterology. 23: 1406-1411. PMID 28293087 DOI: 10.3748/wjg.v23.i8.1406  0.34
2016 Wang X, Hu J, Cao G, Zhu X, Cui Y, Ji X, Li X, Yang R, Chen H, Xu H, Liu P, Li J, Li J, Hao C, Xing B, et al. Phase II Study of Hepatic Arterial Infusion Chemotherapy with Oxaliplatin and 5-Fluorouracil for Advanced Perihilar Cholangiocarcinoma. Radiology. 160572. PMID 27820684 DOI: 10.1148/radiol.2016160572  0.339
2015 Chen H, Zhang J, Cao G, Liu P, Xu H, Wang X, Zhu X, Gao S, Guo J, Zhu L, Zhang P. Target hepatic artery regional chemotherapy and bevacizumab perfusion in liver metastatic colorectal cancer after failure of first-line or second-line systemic chemotherapy. Anti-Cancer Drugs. PMID 26566233 DOI: 10.1097/CAD.0000000000000290  0.356
2014 Cao G, Zhu X, Li J, Shen L, Yang R, Chen H, Wang X, Gao S, Xu H, Zhu L, Liu P, Guo J. A comparative study between Embosphere(®) and conventional transcatheter arterial chemoembolization for treatment of unresectable liver metastasis from GIST. Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu. 26: 124-31. PMID 24653635 DOI: 10.3978/j.issn.1000-9604.2014.02.11  0.372
2014 Chen H, Liu P, Xu HF, Wang XD, Zhu X, Gao S, Cao G, Zhu LZ, Guo JH. Low-dose, short-interval target vessel regional chemotherapy through the hepatic artery combined with transarterial embolization in gastric cancer patients with liver metastases after failure of first-line or second-line chemotherapy: a preliminary analysis. Anti-Cancer Drugs. 25: 92-100. PMID 24185381 DOI: 10.1097/CAD.0000000000000027  0.372
Show low-probability matches.